Spectral Medical, Inc. (EDT.TO)
1.00
-0.03
(-2.91%)
CAD |
TSX |
Nov 13, 16:00
Spectral Medical Enterprise Value : 321.20M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 321.20M |
| November 12, 2026 | 330.06M |
| November 11, 2026 | 341.89M |
| November 10, 2026 | 341.89M |
| November 09, 2026 | 344.85M |
| November 06, 2026 | 312.33M |
| November 05, 2026 | 312.33M |
| November 04, 2026 | 318.24M |
| November 03, 2026 | 306.41M |
| November 02, 2026 | 330.06M |
| October 30, 2026 | 330.06M |
| October 29, 2026 | 300.50M |
| October 28, 2026 | 285.72M |
| October 27, 2026 | 309.37M |
| October 26, 2026 | 318.24M |
| October 23, 2026 | 321.20M |
| October 22, 2026 | 344.85M |
| October 21, 2026 | 347.80M |
| October 20, 2026 | 350.76M |
| October 19, 2026 | 350.76M |
| October 16, 2026 | 341.89M |
| October 15, 2026 | 350.76M |
| October 14, 2026 | 353.72M |
| October 13, 2026 | 350.76M |
| October 09, 2026 | 353.72M |
| Date | Value |
|---|---|
| October 08, 2026 | 362.59M |
| October 07, 2026 | 344.85M |
| October 06, 2026 | 368.50M |
| October 05, 2026 | 353.72M |
| October 02, 2026 | 374.41M |
| October 01, 2026 | 374.41M |
| September 30, 2026 | 362.59M |
| September 29, 2026 | 367.39M |
| September 28, 2026 | 367.39M |
| September 25, 2026 | 367.39M |
| September 24, 2026 | 361.51M |
| September 23, 2026 | 349.77M |
| September 22, 2026 | 355.64M |
| September 21, 2026 | 343.90M |
| September 18, 2026 | 370.32M |
| September 17, 2026 | 387.93M |
| September 16, 2026 | 393.80M |
| September 15, 2026 | 396.74M |
| September 14, 2026 | 402.61M |
| September 11, 2026 | 393.80M |
| September 10, 2026 | 393.80M |
| September 09, 2026 | 393.80M |
| September 08, 2026 | 393.80M |
| September 04, 2026 | 393.80M |
| September 03, 2026 | 402.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Resverlogix Corp. | 135.88M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 15.23M |
| Restart Life Sciences Corp. | 3.639M |
| Defence Therapeutics Inc | 21.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.101M |
| Revenue (Quarterly) | 0.275M |
| Total Expenses (Quarterly) | -4.826M |
| EPS Diluted (Quarterly) | 0.0144 |
| Gross Profit Margin (Quarterly) | -426.5% |
| Earnings Yield | -0.42% |
| Normalized Earnings Yield | -4.14 |